FDA Drug Application (022401) for TWYNSTA by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number022401
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE;40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTWYNSTA
Active IngredientAMLODIPINE BESYLATE; TELMISARTAN

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21
List of drugs with Active Ingredient TELMISARTAN7


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM